{"id":"W4390798532","doi":"10.1093/jacamr/dlad152","title":"Activity of ceftolozane/tazobactam, imipenem/relebactam and ceftazidime/avibactam against clinical Gram-negative isolates—SMART United States 2019–21","year":2023,"lang":"en","type":"article","venue":"JAC-Antimicrobial Resistance","topic":"Antibiotic Resistance in Bacteria","field":"Biochemistry, Genetics and Molecular Biology","cited_by":22,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Manitoba","funders":"Merck Sharp and Dohme; Merck","keywords":"Ceftazidime/avibactam; Meropenem; Pseudomonas aeruginosa; Avibactam; Imipenem; Microbiology; Medicine; Klebsiella pneumoniae; Tazobactam; Broth microdilution; Antimicrobial; Ceftazidime; Antibiotic resistance; Biology; Minimum inhibitory concentration; Antibiotics; Escherichia coli; Bacteria","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007912088,0.0005806037,0.0008868432,0.0002391788,0.0002493864,0.000104208,0.0005701696,0.0005848376,0.00002535935],"category_scores_gemma":[0.0008559371,0.0005801397,0.0003308483,0.0008533483,0.0009861204,0.00004065532,0.000390366,0.0004371725,0.00005472285],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004770066,"about_ca_system_score_gemma":0.0002036799,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001474748,"about_ca_topic_score_gemma":0.0003282313,"domain_scores_codex":[0.9961614,0.0004601325,0.001026822,0.001196987,0.0002810783,0.0008735561],"domain_scores_gemma":[0.9971775,0.0004011919,0.0007712893,0.001022183,0.0003964022,0.0002313786],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.002493965,0.0002788713,0.02643726,0.0002642009,0.0003310983,0.00003045077,0.0001026802,0.00004445819,0.907513,0.00004960554,0.06120803,0.001246415],"study_design_scores_gemma":[0.003222466,0.0005017753,0.3165078,0.0004890215,0.0001519053,0.00001579813,0.0001671538,0.0001999452,0.5884715,0.0001615534,0.0887919,0.001319204],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9963898,0.0002548949,0.0001730538,0.0006580686,0.0005707737,0.0005783383,0.0006073578,0.0001032884,0.0006643984],"genre_scores_gemma":[0.9845368,0.007858157,0.001843989,0.0004123279,0.0001720974,0.000009873249,0.0009236835,0.0001082987,0.004134834],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3190415,"threshold_uncertainty_score":0.999665,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01352947707765101,"score_gpt":0.2835604516133633,"score_spread":0.2700309745357123,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}